The Centers for Medicare & Medicaid Services (CMS) announced a significant increase in payment rates for Medicare Advantage plans for the year 2027. This decision, finalized on February 2, 2026, will lead to a 2.48% rise in average payments, amounting to over $13 billion. The hike contrasts sharply with an earlier proposal in January, which suggested only a 0.09% increase. This initial proposal negatively affected shares of health insurers, but the final announcement resulted in a surge in stock prices, with UnitedHealth and CVS Health seeing gains of over 9% during after-hours trading, while Humana’s stock increased by approximately 12%.
CMS Administrator Dr. Mehmet Oz emphasized that the adjustments are designed to enhance the affordability of coverage and provide tangible value to patients relying on Medicare Advantage and Part D plans. The payment rate is critical as it influences how insurers set monthly premiums and benefits, ultimately impacting their profitability.
Medicare Advantage plans are private insurance options contracted by Medicare, and currently, over half of Medicare beneficiaries are enrolled in these plans, attracted by lower premiums and additional benefits not provided by traditional Medicare.
Why this story matters:
- The payment increase significantly impacts the healthcare landscape and stock market for insurers.
Key takeaway:
- The finalized increase in Medicare Advantage payment rates marks a dramatic shift from the initial proposal, enhancing financial prospects for health insurers.
Opposing viewpoint:
- While the increase is beneficial to insurers, concerns remain about the long-term sustainability of Medicare Advantage programs and their affordability for beneficiaries.
